These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 8182625

  • 1. Effect of etodolac on methotrexate pharmacokinetics in patients with rheumatoid arthritis.
    Anaya JM, Fabre D, Bressolle F, Bologna C, Alric R, Cocciglio M, Dropsy R, Sany J.
    J Rheumatol; 1994 Feb; 21(2):203-8. PubMed ID: 8182625
    [Abstract] [Full Text] [Related]

  • 2. Lack of interaction between bromfenac and methotrexate in patients with rheumatoid arthritis.
    Gumbhir-Shah K, Cevallos WH, DeCleene SA, Korth-Bradley JM.
    J Rheumatol; 1996 Jun; 23(6):984-9. PubMed ID: 8782127
    [Abstract] [Full Text] [Related]

  • 3. Combined oral cyclosporin and methotrexate therapy in patients with rheumatoid arthritis elevates methotrexate levels and reduces 7-hydroxymethotrexate levels when compared with methotrexate alone.
    Fox RI, Morgan SL, Smith HT, Robbins BA, Choc MG, Baggott JE.
    Rheumatology (Oxford); 2003 Aug; 42(8):989-94. PubMed ID: 12730515
    [Abstract] [Full Text] [Related]

  • 4. Folic acid alters methotrexate availability in patients with rheumatoid arthritis.
    Bressolle F, Kinowski JM, Morel J, Pouly B, Sany J, Combe B.
    J Rheumatol; 2000 Sep; 27(9):2110-4. PubMed ID: 10990220
    [Abstract] [Full Text] [Related]

  • 5. Lack of correlation between pharmacokinetics and efficacy of low dose methotrexate in patients with rheumatoid arthritis.
    Lafforgue P, Monjanel-Mouterde S, Durand A, Catalin J, Acquaviva PC.
    J Rheumatol; 1995 May; 22(5):844-9. PubMed ID: 8587070
    [Abstract] [Full Text] [Related]

  • 6. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment.
    Stamp LK, O'Donnell JL, Chapman PT, Zhang M, Frampton C, James J, Barclay ML.
    Arthritis Rheum; 2009 Aug; 60(8):2248-56. PubMed ID: 19644853
    [Abstract] [Full Text] [Related]

  • 7. Combination therapy with methotrexate and hydroxychloroquine for rheumatoid arthritis increases exposure to methotrexate.
    Carmichael SJ, Beal J, Day RO, Tett SE.
    J Rheumatol; 2002 Oct; 29(10):2077-83. PubMed ID: 12375315
    [Abstract] [Full Text] [Related]

  • 8. Total and free methotrexate pharmacokinetics in elderly patients with rheumatoid arthritis. A comparison with young patients.
    Bressolle F, Bologna C, Kinowski JM, Arcos B, Sany J, Combe B.
    J Rheumatol; 1997 Oct; 24(10):1903-9. PubMed ID: 9330930
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Is there an optimal time to administer methotrexate in the treatment of rheumatoid arthritis?
    Carpentier N, Bertin P, Marquet P, Sabot C, Bonnet C, Debord J, Lachâtre G, Trèves R.
    J Rheumatol; 1998 Jul; 25(7):1270-5. PubMed ID: 9676755
    [Abstract] [Full Text] [Related]

  • 11. Oral administration of an easily prepared solution of injectable methotrexate diluted in water: A comparison of serum concentrations vs methotrexate tablets and clinical utility.
    Marshall PS, Gertner E.
    J Rheumatol; 1996 Mar; 23(3):455-8. PubMed ID: 8832982
    [Abstract] [Full Text] [Related]

  • 12. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M, Chladek J, Simkova M, Vaneckova J, Grim J, Martinkova J.
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [Abstract] [Full Text] [Related]

  • 13. Splitting high-dose oral methotrexate improves bioavailability: a pharmacokinetic study in patients with rheumatoid arthritis.
    Hoekstra M, Haagsma C, Neef C, Proost J, Knuif A, van de Laar M.
    J Rheumatol; 2006 Mar; 33(3):481-5. PubMed ID: 16463431
    [Abstract] [Full Text] [Related]

  • 14. Is there an interaction between low doses of corticosteroids and methotrexate in patients with rheumatoid arthritis? A pharmacokinetic study in 33 patients.
    Lafforgue P, Monjanel-Mouterde S, Durand A, Catalin J, Acquaviva PC.
    J Rheumatol; 1993 Feb; 20(2):263-7. PubMed ID: 8474062
    [Abstract] [Full Text] [Related]

  • 15. Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis.
    Hoekstra M, Haagsma C, Neef C, Proost J, Knuif A, van de Laar M.
    J Rheumatol; 2004 Apr; 31(4):645-8. PubMed ID: 15088287
    [Abstract] [Full Text] [Related]

  • 16. Methotrexate kinetics in rheumatoid arthritis: is there an interaction with nonsteroidal antiinflammatory drugs?
    Ahern M, Booth J, Loxton A, McCarthy P, Meffin P, Kevat S.
    J Rheumatol; 1988 Sep; 15(9):1356-60. PubMed ID: 3199396
    [Abstract] [Full Text] [Related]

  • 17. Celecoxib, a specific COX-2 inhibitor, has no significant effect on methotrexate pharmacokinetics in patients with rheumatoid arthritis.
    Karim A, Tolbert DS, Hunt TL, Hubbard RC, Harper KM, Geis GS.
    J Rheumatol; 1999 Dec; 26(12):2539-43. PubMed ID: 10606360
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis.
    Dalrymple JM, Stamp LK, O'Donnell JL, Chapman PT, Zhang M, Barclay ML.
    Arthritis Rheum; 2008 Nov; 58(11):3299-308. PubMed ID: 18975321
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.